Yi Jun Lu
Corporate Officer/Principal presso CANBRIDGE PHARMACEUTICALS INC.
Profilo
Yi Jun Lu is currently the General Manager at CANbridge Pharmaceuticals Inc. Prior to this, he worked as the Head of Hemophilia & Rare Disease at Takeda (China) Holdings Co. Ltd.
for a brief period in 2020 and as the Head of Hematology at Shire Bioscience (Shanghai) Co., Ltd.
from 2018 to 2019.
Posizioni attive di Yi Jun Lu
| Società | Posizione | Inizio |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Corporate Officer/Principal | 09/11/2020 |
Precedenti posizioni note di Yi Jun Lu
| Società | Posizione | Fine |
|---|---|---|
| Takeda (China) Holdings Co. Ltd. | Corporate Officer/Principal | 01/11/2020 |
| Shire Bioscience (Shanghai) Co., Ltd. | Corporate Officer/Principal | 01/04/2019 |
Esperienze
Posizioni ricoperte
Relazioni
29
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
| Takeda (China) Holdings Co. Ltd. | |
| Shire Bioscience (Shanghai) Co., Ltd. |
- Borsa valori
- Insiders
- Yi Jun Lu